OXT and pulmonary arterial hypertension: For PPH ≥ 1000 mL, analysis of placebo‐controlled RCTs showed that oxytocin was associated with a significant decrease in the risk of PPH (5 RCTs, 2954 participants; OR 0.61, 95% CI 0.51 to 0.71, Table S7).